Horwitz, Marcus Aaron

University of California, Los Angeles · Internal Medicine (NIH department code)

From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.

FY2023 NIH rank #3,473

Unclaimed recordClaim profile

Sustained Excellence
R01 Holder
Long-Funded

Researcher identity and coverage

Current affiliation: Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity: Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD: No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage: FY2006 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

FY2023 award categories

Internal Medicine

NIH Funding · FY2023

Linked Award Amount

$2.1M

Full award amounts, FY2023

Award Records

Records listing this PI

Award-Linked Rank

#3,473

By linked amount among FY2023 PIs

Earliest Year Loaded

2006

ScienceDex PI coverage

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2023 award records by amount

NIH award records listing Horwitz, Marcus Aaron as a PI. Multi-PI records show the full award amount for context.

5R01AI148122-03R01Contact PI
Development of a novel TB vaccine safer and more effective than BCG based on a precisely controlled replication-limited Mycobacterium tuberculosis engineered for optimal in vivo growth and clearance
University of California, Los Angeles · Internal Medicine (NIH department code)
$780K
award amount
5R01AI141390-05R01Contact PI
Development of a Safe and Potent Vaccine Against Melioidosis using the LVS dcapB Vector Platform
University of California, Los Angeles · Internal Medicine (NIH department code)
$620.7K
award amount
5R01AI151055-04R01Contact PI
Composition, Atomic Structure and Function of the Francisella Type 6 Secretion System, a Distinct Subtype Essential for Phagosomal Escape, Intracellular Replication, and Virulence
University of California, Los Angeles · Internal Medicine (NIH department code)
$549.7K
award amount
3R01AI141390-05S1R01Contact PI
Development of a Safe and Potent Vaccine Against Melioidosis using the LVS dcapB Vector Platform
University of California, Los Angeles · Internal Medicine (NIH department code)
$155.1K
award amount

Award organization

Organizations that administered FY2023 awards listing Horwitz, Marcus Aaron as a PI.

FY2023 award administered by University of California, Los Angeles (CA).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

2006
First NIH Award
University of California, Los Angeles
2006
$500K Cumulative Funding
2006
$1M Cumulative Funding
2006
$2M Cumulative Funding
2006
Entered Top 50% Nationally
Ranked #1627
2006
Entered Top 25% Nationally
Ranked #1627
2006
Entered Top 10% Nationally
Ranked #1627
2008
$5M Cumulative Funding
2012
$10M Cumulative Funding
2012
R01 Grant Holder
2022
$25M Cumulative Funding

Explore further

Find collaborators for Horwitz, Marcus Aaron

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →